Clinical Practice Guideline: Executive Summary
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

https://doi.org/10.1016/j.jacc.2018.11.002Get rights and content
Under an Elsevier user license
open archive

Key Words

ACC/AHA Clinical Practice Guidelines
Guidelines
biomarkers
coronary artery calcium score
pharmacological
cardiovascular disease
cholesterol
LDL-cholesterol
diabetes mellitus
drug therapy
hydroxymethylglutaryl-CoA reductase inhibitors/statins
hypercholesterolemia
lipids
patient compliance
primary prevention
risk assessment
risk reduction discussion
risk treatment discussion
secondary prevention
ezetimibe
proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors

Cited by (0)

This document was approved by the American College of Cardiology Clinical Policy Approval Committee, the American Heart Association Science Advisory and Coordinating Committee, American Association of Cardiovascular and Pulmonary Rehabilitation, American Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association in October 2018, and the American Heart Association Executive Committee in October 2018.

The American College of Cardiology requests that this document be cited as follows: Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:3168–3209.

This article has been copublished in Circulation.

Copies: This document is available on the websites of the American College of Cardiology (www.acc.org) and the American Heart Association (professional.heart.org). For copies of this document, please contact the Elsevier Inc. Reprint Department via fax (212-633-3820) or e-mail ([email protected]).

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology. Requests may be completed online via the Elsevier site (https://www.elsevier.com/about/policies/copyright/permissions).

ACC/AHA Representative.

AACVPR Representative.

ACC/AHA Task Force on Clinical Practice Guidelines Liaison.

§

Prevention Subcommittee Liaison.

PCNA Representative.

AAPA Representative.

∗∗

AGS Representative.

††

ADA Representative.

‡‡

PM Representative.

§§

ACPM Representative.

‖‖

NLA Representative.

¶¶

APhA Representative.

∗∗∗

ASPC Representative.

†††

ABC Representative.